Moleculin Biotech (FRA:MOL) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Moleculin Biotech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Moleculin Biotech's Free Cash Flow for the three months ended in Mar. 2024 was €-6.18 Mil. Moleculin Biotech's Revenue for the three months ended in Mar. 2024 was €0.00 Mil. Therefore, Moleculin Biotech's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Moleculin Biotech's current FCF Yield % is -269.58%.

The historical rank and industry rank for Moleculin Biotech's FCF Margin % or its related term are showing as below:

FRA:MOL's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -138.52
* Ranked among companies with meaningful FCF Margin % only.

Moleculin Biotech FCF Margin % Historical Data

The historical data trend for Moleculin Biotech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moleculin Biotech FCF Margin % Chart

Moleculin Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Moleculin Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Moleculin Biotech's FCF Margin %

For the Biotechnology subindustry, Moleculin Biotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moleculin Biotech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moleculin Biotech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Moleculin Biotech's FCF Margin % falls into.

Moleculin Biotech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Moleculin Biotech's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-22.215	/	0
	=	%

Moleculin Biotech's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-6.18	/	0
	=	%

Moleculin Biotech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Moleculin Biotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Moleculin Biotech (FRA:MOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moleculin Biotech Inc (FRA:MOL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

MBRX:USA 0K2H:UK

Address

5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007

Website

https://www.moleculin.com

Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.

Moleculin Biotech (FRA:MOL) Headlines

No Headlines